PROVECTUS BIOPHARMACEUTICALS, INC.

OTC:PVCT

Pharmaceutical Preparations·KNOXVILLE, TN

CEO

Pershing Edward

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-K/A	FY 2024	12/31/24	5/16/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

News (8-K)

80 shown

Filed	Type	Description
2/2/26	Other	Amendments to Articles of Incorporation or Bylaws	→
6/20/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/18/25	Reg FD	Regulation FD Disclosure	→
4/16/25	Other	Changes in Registrant's Certifying Accountant	→
1/22/25	Agreement	Entry into a Material Definitive Agreement	→
12/26/24	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
5/5/25	ARS	ARS	→
5/9/24	ARS	ARS	→
5/11/23	ARS	ARS	→
3/6/17	424B3	424B3	→
2/21/17	424B3	424B3	→
2/9/17	424B3	424B3	→
↓

Filing History(1002 filings)

TypeDateAccessionPeriodSize

Mar 6, 2026

0001493152-26-0090814

Mar 5, 2026

6.6 KB

Feb 27, 2026

0001493152-26-0082904

Feb 26, 2026

6.6 KB

Feb 23, 2026

0001493152-26-0077324

Feb 20, 2026

8.8 KB

Feb 23, 2026

0001493152-26-0077294

Feb 19, 2026

6.6 KB

Feb 17, 2026

0001493152-26-006978

Feb 12, 2026

6.6 KB

Feb 11, 2026

0001493152-26-0062634

Feb 9, 2026

6.0 KB

Feb 9, 2026

0001493152-26-0057444

Feb 5, 2026

6.6 KB

8-K

Feb 2, 2026

0001493152-26-0047308-K

Jan 30, 2026

231.9 KB

Feb 2, 2026

0001493152-26-0047084

Jan 30, 2026

8.8 KB

Jan 29, 2026

0001493152-26-0042364

Jan 28, 2026

6.6 KB

Jan 16, 2026

0001493152-26-0025084

Jan 16, 2026

8.8 KB

Dec 15, 2025

0001493152-25-027846

Dec 11, 2025

6.6 KB

Dec 8, 2025

0001493152-25-0265674

Dec 5, 2025

6.6 KB

SCHEDULE 13D

Dec 8, 2025

0001493152-25-026550

—

12.2 KB

SCHEDULE 13D/A

Dec 1, 2025

0001493152-25-025639

—

13.4 KB

Nov 28, 2025

0001493152-25-025335

Nov 26, 2025

6.6 KB

Nov 21, 2025

0001493152-25-0245804

Nov 20, 2025

6.6 KB

Nov 14, 2025

0001493152-25-0232384

Nov 13, 2025

6.6 KB

10-Q

Nov 13, 2025

0001493152-25-02222910-Q

Sep 30, 2025

5.8 MB

Nov 7, 2025

0001493152-25-0212004

Nov 6, 2025

6.6 KB

Oct 31, 2025

0001493152-25-0203844

Oct 30, 2025

6.6 KB

Oct 24, 2025

0001493152-25-0193264

Oct 23, 2025

6.6 KB

Oct 17, 2025

0001493152-25-018381

Oct 16, 2025

8.8 KB

Oct 14, 2025

0001493152-25-0179564

Oct 10, 2025

6.6 KB

Oct 9, 2025

0001493152-25-017543

Oct 3, 2025

6.6 KB

25 filings shown

Filed	Form	Description
6/18/25	DEFA14A	DEFA14A	→
5/1/25	DEFA14A	DEFA14A	→
5/1/25	DEF 14A	DEF 14A	→
4/18/25	PRE 14A	PRE 14A	→
6/20/24	DEFA14A	DEFA14A	→
5/6/24	DEFA14A	DEFA14A	→
↓

PROVECTUS BIOPHARMACEUTICALS, INC.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(1002 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
2/27/26	4	4	→
2/23/26	4	4	→
2/23/26	4	4	→
2/17/26	4	4	→
2/11/26	4	4	→
↓

Filed	Form	Description
12/8/25	SCHEDULE 13D	SCHEDULE 13D	→
12/1/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
7/17/24	D	D	→
10/28/22	D	D	→
8/30/21	D	D	→
4/21/17	DFAN14A	DFAN14A	→
↓